Navigation Links
UCB Announces Positive Results From Phase II Clinical Trial of Investigational Anti-Epilepsy Drug Brivaracetam
Date:12/3/2007

and partial onset seizures in adults with epilepsy. Keppra(R)injection is an alternative for adult patients when oral administration is temporarily not feasible.

Keppra(R) tablets and oral solution are associated with the occurrence of central nervous system adverse events including somnolence and fatigue, behavioral abnormalities, and coordination difficulties, as well as hematological abnormalities. In pediatric patients 4 -16 years of age experiencing partial onset seizures, the most common adverse events associated with Keppra(R) in combination with other AEDs were somnolence, accidental injury, hostility, nervousness and asthenia. In adults experiencing partial onset seizures, the most common adverse events associated with Keppra(R) in combination with other AEDs were somnolence, asthenia, infection and dizziness. In patients 12 years of age and older experiencing myoclonic seizures with JME, the most common adverse events associated with Keppra(R) in combination with other AEDs were somnolence, neck pain, and pharyngitis. In patients 6 years of age and older experiencing PGTC seizures with idiopathic generalized epilepsy, the most common adverse event associated with Keppra(R) in combination with other AEDs was nasopharyngitis.

The adverse events that result from Keppra(R) injection use for myoclonic seizures in JME and partial onset seizures in adults include all of those associated with Keppra(R) tablets and oral solution.

Dosing for all Keppra(R) formulations must be individualized according to the patient's renal function status.

About UCB

UCB, Brussels, Belgium (http://www.ucb-group.com) is a global leader in the biopharmaceutical industry dedicated to the research, development and commercialisation of innovative pharmaceutical and biotechnology products in the fields of central nervous system disorders, allergy/respiratory diseases, immune and inflammatory disorders
'/>"/>

SOURCE UCB, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
2. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
3. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
4. HEI, Inc. Announces Sale of RFID Division Assets
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
6. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
7. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
8. Brooke Franchise Corporation Announces Selected July Results
9. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
11. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... Companies in the Benefit ... maintaining and managing their employees' benefits. These benefits ... to individual retirement accounts, maternity leave, vacation time ... administration of workers' compensation for companies that opt ... on conditions in the labor market and companies' ...
(Date:3/31/2015)... (PRWEB) March 31, 2015 RE/MAX agents ... 2014 for Children’s Miracle Network Hospitals® – most of ... the RE/MAX Miracle Home and Miracle Property programs, offices ... to provide ongoing support to their local children’s hospitals, ... , Since partnering with Children’s Miracle Network Hospitals ...
(Date:3/31/2015)... (PRWEB) March 31, 2015 St. Joseph ... growing network of leading healthcare systems, major physician groups ... information for the benefit of patients. The health information ... that supports well coordinated care throughout the continuum of ... a long tradition of providing services to a broad ...
(Date:3/31/2015)... Chicago, Illinois (PRWEB) March 31, 2015 ... NetZoom Visio Stencils Device Library for documenting and ... the following Visio Stencils: , Manufacturer / ... Dell PowerEdge r720, Dell PowerEdge r520, Dell PowerEdge ... IBM Power 8 Series, EMC VMAX 100K, VMAX ...
(Date:3/31/2015)... Indiana (PRWEB) March 31, 2015 ... DeRose in Youngstown, Ohio in 1987. This ... the curve with not just customer satisfaction, but ... been added to the well-stocked arsenal of Yesco ... by American Green Technology® (AGT). The patented environmental ...
Breaking Medicine News(10 mins):Health News:Benefit Administration Services in the US Industry Market Research Report Now Available from IBISWorld 2Health News:Benefit Administration Services in the US Industry Market Research Report Now Available from IBISWorld 3Health News:RE/MAX Agents Raise $8.75 Million for Children's Hospitals in 2014 2Health News:RE/MAX Agents Raise $8.75 Million for Children's Hospitals in 2014 3Health News:St. Joseph Medical Center Joins Other Leading Healthcare Systems Participating in Greater Houston Healthconnect 2Health News:Altima Adds More Hardware Devices to its NetZoom™ Visio® Stencils Device Library 2Health News:American Green Technology® Signs Exclusive Agreement to Distribute Health Risk Management System in Midwest 2
... Osteotech, Inc.,(Nasdaq: OSTE ) announced today that third ... third quarter 2006 revenue of $23.4,million. Revenue from Osteotech,s ... for the three months ended September 30,2007 as compared ... for the,third quarter of 2006. Gross margin improved to ...
... 6 /PRNewswire-FirstCall/ - Bioniche Life Sciences,Inc. (TSX: BNC), ... Cameron Groome, Executive,Vice-President, Corporate & Strategic Development, will ... Healthcare Conference in New York City,tomorrow. Mr. Groome ... the Holmes,II Room of the New York Palace ...
... by web cast-, TORONTO, Nov. 6 /PRNewswire-FirstCall/ ... in the research,development and commercialization of pharmaceutical products ... that on,Wednesday, November 7, 2007, at 10:30 a.m. ... and CEO will present a corporate overview of ...
... Elite Books, TUCSON, Ariz., Nov. 5 We all ... the development of Alzheimer,s Disease and heart,disease, along with a ... In her seminal book, The Apo E Gene Diet: ... Body,s Own Genes,(Elite, Hardcover, $27.95, November 1, 2007), Pamela McDonald, ...
... 5 StatSure Diagnostic,Systems, Inc. (OTC Bulletin Board: ... Administration ("FDA"), through its Center for Devices and,Radiological ... Laboratory,Improvements Amendments of 1988 ("CLIA") for an HIV ... The HIV 1/2 product,is marketed and distributed worldwide ...
... offices could ... YORK, Nov. 5 Group Health Incorporated (GHI) and,HIP ... educational seminar in,New York City on November 6 for ... be held at HIP,headquarters, 55 Water St., will provide ...
Cached Medicine News:Health News:Osteotech Reports 2007 Third Quarter Financial Results; Core Segment Revenue Increased 28%; Gross Margin Improved to 55%; Diluted Earnings Per Share of $.09 2Health News:Osteotech Reports 2007 Third Quarter Financial Results; Core Segment Revenue Increased 28%; Gross Margin Improved to 55%; Diluted Earnings Per Share of $.09 3Health News:Osteotech Reports 2007 Third Quarter Financial Results; Core Segment Revenue Increased 28%; Gross Margin Improved to 55%; Diluted Earnings Per Share of $.09 4Health News:Osteotech Reports 2007 Third Quarter Financial Results; Core Segment Revenue Increased 28%; Gross Margin Improved to 55%; Diluted Earnings Per Share of $.09 5Health News:Bioniche to Present at Rodman & Renshaw 9th Annual Healthcare Conference 2Health News:Lorus announces presentation of corporate overview at the Rodman and Renshaw Annual Healthcare Conference 2Health News:Groundbreaking Apo E Gene Diet Linked to Alzheimer's Disease and Heart Disease Prevention 2Health News:StatSure's Patented HIV 'Barrel' Technology Receives CLIA Waiver From FDA 2Health News:StatSure's Patented HIV 'Barrel' Technology Receives CLIA Waiver From FDA 3Health News:GHI and HIP Lead Effort to Expand Electronic Health Record System Throughout the City of New York 2
(Date:3/31/2015)... Accelerated orthodontic treatment will be a ... 2015 Annual Session, May 15-19, as seven of ... AcceleDent ® . Manufactured by OrthoAccel ® ... is a FDA-cleared, Class II medical device that ... 50 percent with just 20 minutes of daily ...
(Date:3/31/2015)... 2015 Ryan & Maniskas, LLP ... of Hyperion Therapeutics, Inc. ("Hyperion" or the "Company") (NASDAQ: ... and other violations of law related to the Company,s ... in a transaction valued at approximately $1.1 billion. ... like to learn more about this class action or ...
(Date:3/31/2015)... 2015 Medela has announced the addition ... ® Motion™-Endure personal pumps to its Negative Pressure ... These new devices, along with the Invia ® ... provide innovative, high-quality NPWT solutions, designed to provide ... "We are happy to be able ...
Breaking Medicine Technology:Leading Orthodontists to Advance Accelerated Treatment at AAO 2015 2Leading Orthodontists to Advance Accelerated Treatment at AAO 2015 3Ryan & Maniskas, LLP Announces Investigation of Hyperion Therapeutics, Inc. 2Medela Launches Product Line to Support Individualized Care For Negative Pressure Wound Therapy Patients 2
... BEIJING , July 7 ... "Company"), a growing developer,manufacturer and seller of medicine and drugs in ... will present at the Global Hunter,Securities 2010 China Conference held ... are noted below. , , Date: ...
... BEIJING , July 7 /PRNewswire-Asia-FirstCall/ -- ... CCM ), operator of,the largest network of radiotherapy ... it has filed its annual report for the fiscal year ... U.S. Securities and Exchange,Commission on June 30, 2010 . ...
Cached Medicine Technology:Lotus Pharmaceuticals to Present at Global Hunter Securities 2010 China Conference 2Concord Medical Files 2009 Annual Report on Form 20-F 2
... molecular labs a more advanced alternative for ... MGB technology, combined with post-PCR dissociation melt ... provide molecular labs more powerful tools for ... or genetic mutations associated with disease, as ...
... ASRs* are specifically designed for PCR ... two-color fluorescence detection systems. The NGEN ... detection of mutations associated with cystic ... well as reagents for the detection ...
... MGB Alert Detection Reagents provide molecular ... PCR based assays. By using our MGB ... analysis, Nanogen is now able to provide ... nucleic acid sequences of specific organisms or ...
... NGEN-brand ASRs* are specifically designed for ... with two-color fluorescence detection systems. The ... the detection of mutations associated with ... as well as reagents for the ...
Medicine Products: